Publications by authors named "Sabine Bader"

Claim this Profile
T
Targeting Tumor Cells with Anti-CD44 Antibody Triggers Macrophage-Mediated Immune Modulatory Effects in a Cancer Xenograft Model.
Daniela Maisel, Fabian Birzele, Edgar Voss, Adam Nopora, Sabine Bader

PLoS One· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An ex vivo potency assay to assess active drug levels of a GLP-1 agonistic peptide during preclinical safety studies.
Martin Schäfer, Steven Challand, Eginhard Schick, Sabine Bader, Dominik Hainzl

Bioanalysis· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MDM2 antagonist clinical response association with a gene expression signature in acute myeloid leukaemia.
Hua Zhong, Gong Chen, Lori Jukofsky, David Geho, Sung Won Han, Sabine Bader

Br J Haematol· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Protein Profiles From Treated Xenograft Tumor Models Identifies an Antibody Panel for Formalin-fixed and Paraffin-embedded (FFPE) Tissue Analysis by Reverse Phase Protein Arrays (RPPA).
Sabine Bader, Magdalena Zajac, Thomas Friess, Elisabeth Ruge, Natascha Rieder

Mol Cell Proteomics· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical pharmacokinetics, pharmacodynamics, and efficacy of RG7116: a novel humanized, glycoengineered anti-HER3 antibody.
Georgina Meneses-Lorente, Thomas Friess, Irene Kolm, Gabriele Hölzlwimmer, Sabine Bader

Cancer Chemother Pharmacol· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of efficacy of a new MEK inhibitor, RO4987655, in human tumor xenografts by [(18)F] FDG-PET imaging combined with proteomic approaches.
Tetyana Tegnebratt, Elisabeth Ruge, Sabine Bader, Nobuya Ishii, Satoshi Aida

EJNMMI Res· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced anti-tumor activity of the glycoengineered type II CD20 antibody obinutuzumab (GA101) in combination with chemotherapy in xenograft models of human lymphoma.
Frank Herting, Thomas Friess, Sabine Bader, Gunter Muth, Gabriele Hölzlwimmer

Leuk Lymphoma· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determination of phosphorylated proteins in tissue specimens requires high-quality samples collected under stringent conditions.
Corinna Wolf, Tiantom Jarutat, Suzana Vega Harring, Kristin Haupt, Galina Babitzki, Sabine Bader

Histopathology· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methylnaltrexone for the treatment of opioid-induced constipation.
Sabine Bader, Thorsten Dürk, Gerhild Becker

Expert Rev Gastroenterol Hepatol· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of bacteria by pyrolysis gas chromatography-differential mobility spectrometry and isolation of chemical components with a dependence on growth temperature.
Satendra Prasad, Karisa M Pierce, Hartwig Schmidt, Jaya V Rao, Robert Güth, Sabine Bader

Analyst· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis